Palomar Medical Technologies
This article was originally published in The Gray Sheet
Laser hair removal device firm's planned recapitalization includes a one-for-seven reverse stock split. At an April 21 meeting shareholders also approved the sale of the firm's Star Medical Technologies semiconductor laser subsidiary to Coherent for $65 mil. in cash and an ongoing 7.5% royalty. Palomar owns 82% of Star and anticipates a net gain of about $49 mil. before taxes. Closing of the deal, announced in December, is expected "shortly" ("The Gray Sheet" Dec. 14, 1998, p. 8)
You may also be interested in...
Palomar grants Laserscope a non-exclusive 7.5% royalty-bearing sublicense to patents in the field of laser hair removal, including U.S. Patent No. 5,595,568 "Permanent Hair Removal Using Optical Pulses," and No. 5,735,844 entitled "Hair Removal Using Optical Pulses." Palomar previously granted a 7.5% sublicense for the same patents to Coherent (1"The Gray Sheet" May 3, 1999, p. 20)
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.